During the past decade, Ascension Via Christi Hospitals Wichita conducted 101 clinical trials. In the 10-year time frame, 101 clinical trials started and 69 clinical trials were completed, i.e. on average, 68.3% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 44 clinical trials were completed. i.e. 151.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ascension Via Christi Hospitals Wichita" #1 sponsor was "National Cancer Institute (NCI)" with 89 trials, followed by "NRG Oncology" with 16 trials sponsored, "Alliance for Clinical Trials in Oncology" with 14 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored and "SWOG Cancer Research Network" with 7 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ascension Via Christi Hospitals Wichita" #1 collaborator was "National Cancer Institute (NCI)" with 57 trials as a collaborator, "NRG Oncology" with 19 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "Cancer and Leukemia Group B" with 3 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Ascension Via Christi Hospitals Wichita" are "Recurrent Breast Carcinoma" (8 trials), "Stage IV Cutaneous Melanoma AJCC v6 and v7" (8 trials), "Fallopian Tube Transitional Cell Carcinoma" (7 trials), "Invasive Breast Carcinoma" (7 trials) and "Fallopian Tube Clear Cell Adenocarcinoma" (6 trials). Many other conditions were trialed in "Ascension Via Christi Hospitals Wichita" in a lesser frequency.

Most popular intervention types in "Ascension Via Christi Hospitals Wichita" are "Drug" (115 trials), "Other" (93 trials), "Biological" (62 trials), "Radiation" (41 trials) and "Procedure" (40 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (58 trials), "Quality-of-Life Assessment" (41 trials), "Paclitaxel" (23 trials), "Carboplatin" (19 trials) and "Questionnaire Administration" (18 trials). Other intervention names were less common.

The vast majority of trials in "Ascension Via Christi Hospitals Wichita" are 121 trials for "All" genders, 29 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Ascension Via Christi Hospitals Wichita". undefined are not yet recruiting, 34 are recruiting, 88 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Ascension Via Christi Hospitals Wichita, 5 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Ascension Via Christi Hospitals Wichita, 7 "Phase 1" clinical trials were conducted, 73 "Phase 2" clinical trials and 84 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".